Heart Metabolics Overview

  • Founded
  • 2004
  • Status
  • Out of Business
  • Employees
  • 4
  • Latest Deal Type
  • Out of Business

Heart Metabolics General Information


Developer of pharmaceutical therapy designed to help in the treatment of hypertrophic cardiomyopathy (HCM). The company's therapy is used in developing perhexiline as a therapeutic for all types of treatment-related to HCM, enabling patients to get cured who are presently in search for the treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 20B Beckett Way
  • Dublin 12
  • Ireland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Heart Metabolics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Nov-2017 000.00 Completed Out of Business
3. Later Stage VC 01-Jan-2015 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 17-Apr-2014 $20M $24M Completed Generating Revenue
1. Early Stage VC 04-Jan-2013 $4M $4M Completed Generating Revenue
To view Heart Metabolics’s complete valuation and funding history, request access »

Heart Metabolics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial